U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production

In a significant move to combat the Covid-19 pandemic, the U.S. government agreed to support a controversial proposal to temporarily waive intellectual property rights for vaccines in a bid to increase global supplies of desperately needed doses.